Follow The Filings

ASTH Astrana Health

Astrana Health earnings company data as of 1:09 PM ET 11/13

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.88 0.71 Miss -19.0%
Rev $1.02B $1.02B In line +0.3%

Insider trades

Open-market buys and sales by ASTH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ASTH insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 21 share withholdings for taxes, 10 stock grants, 4 option exercises, and 3 sales back to the company.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 1.05
8-K 7.01,9.01
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G —
8-K 7.01,9.01
8-K 5.02
8-K 5.02,5.07,9.01
8-K 7.01,9.01
8-K 5.02
10-Q
8-K 2.02,7.01,9.01
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf